085 Abrocitinib improves patient-reported outcomes in patients with moderate to severe atopic dermatitis. Data from RE-DERMA registry

Autor: Murashkin, N., Olisova, O., Kochergin, N., Grabovetskaya, J., Chsherbanev, K., Piterskaya, E., Vurdov, D.

Publikováno v: Journal of Investigative Dermatology; December 2024, Vol. 144 Issue: 12, Number 12 Supplement 1 pS243-S243, 1p